Avidity Biosciences, Inc.
Pioneering targeted RNA therapies that treat the root cause of rare muscle diseases.
RNA | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 3020 CALLAN ROAD, 92121 SAN DIEGO
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Avidity Biosciences, Inc. is a biopharmaceutical company pioneering a new class of RNA therapeutics. The company's proprietary Antibody Oligonucleotide Conjugates (AOC™) platform is designed to revolutionize the delivery of genetic medicines. AOCs combine the tissue selectivity of monoclonal antibodies with the precision of oligonucleotide-based therapies, enabling the targeted delivery of RNA drugs to previously inaccessible cells and tissues, such as muscle. By addressing the root genetic cause of diseases, Avidity is advancing an innovative pipeline of therapeutic candidates. The company's initial focus is on rare muscle diseases, with plans to expand its platform to address unmet patient needs across a wide range of other therapeutic areas.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Avidity Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Avidity Biosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Avidity Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
